Steven Lichtman Stock Analyst Profile - Oppenheimer Research Coverage - Stocknear

Steven Lichtman

Stock Analyst at Oppenheimer

(3.7)
# 2332
Out of 5,478 analysts
80
Total ratings
Success rate
Average return
20 Stocks
Name Action PT Current % Upside Ratings Updated
TNDM Tandem Diabetes Care
Maintains: Outperform
44 22
12.27 79.3% 2 Sep 8, 2025
PODD Insulet
Maintains: Outperform
324 365
341.78 6.79% 5 Sep 8, 2025
BSX Boston Scientific
Upgrades: Outperform
118 125
102.7 21.71% 4 Sep 8, 2025
DXCM DexCom
Maintains: Outperform
95 102
76.22 33.82% 9 Jul 31, 2025
ZBH Zimmer Biomet Holdin...
Maintains: Outperform
145 135
103.08 30.97% 7 Oct 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
10 12
5.57 115.44% 2 Aug 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
103 110
78.3 40.49% 3 Aug 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Perform
92 94
94.05 -0.05% 10 Aug 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
72 65
9.31 598.17% 8 Aug 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
10 11
15.77 -30.25% 5 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
12
10.65 12.68% 2 Apr 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
82 87
85.53 1.72% 1 Feb 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
4
0.75 366.67% 2 Sep 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 9 May 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Perform
273 288
383.34 -24.87% 1 Jul 28, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
105
82.76 26.87% 3 Jul 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Perform
150
27.7 441.52% 1 Jul 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Perform
83 85
66.68 27.47% 2 Sep 4, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 Dec 23, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 Apr 12, 2017